<DOC>
	<DOCNO>NCT00512005</DOCNO>
	<brief_summary>The purpose prospective , non-randomized , single-arm feasibility study evaluate safety feasibility iCoapsys System patient functional mitral valve insufficiency cause annular dilation and/or papillary muscle displacement .</brief_summary>
	<brief_title>VIVID - Valvular Ventricular Improvement Via iCoapsys Delivery - Feasibility Study</brief_title>
	<detailed_description>Functional MR frequent outcome ischemic heart disease dilate cardiomyopathy . Patients functional MR generally normal valvular structure complicate leave ventricular dysfunction . Left ventricular dysfunction often create geometric distortion prevent complete leaflet coaptation , render valve incompetent . Changes induce functional MR may include ( ) dyskinetic akinetic wall segment , ( ii ) dilation valve annulus ( iii ) dilation leave ventricle lead tether chordae tendinae . The iCoapsys Device intend treat patient functional MR . The device indicate patient diseased damage valvular structure cause rheumatic fever , degenerative disease , endocarditis , infiltrative disease congenital disorder .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Key Grade 3 4 functional mitral valve regurgitation per 2D echocardiography . NYHA Class II LVEF great equal 25 % NYHA Class III LVEF great equal 30 % Key History pericarditis . Creatinine &gt; 2.2 time procedure INR &gt; 1.8 time procedure Prior pericardial intervention ( include CABG , pericardiotomy pericardiocentesis ) . Any endovascular therapeutic interventional surgical procedure perform within 30 day prior index procedure ( e.g. , stent placement ) . Any planned therapeutic interventional surgical procedure plan within 30 day follow index procedure Open chest surgery contraindication ( e.g. , acute respiratory distress , endocarditis , myocarditis ) . Structural abnormality mitral valve Valve disease result insufficiency stenosis aortic , pulmonary tricuspid valve require intervention . Pericardial effusion &gt; 5 mm via echocardiography . Posterior wall enddiastolic dimension &gt; 1.3 cm . Left ventricular end diastolic diameter &gt; 7.0 cm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Functional Mitral Regurgitation ( FMR )</keyword>
	<keyword>Ischemic Mitral Regurgitation</keyword>
	<keyword>Less invasive repair</keyword>
	<keyword>Percutaneous MV repair</keyword>
	<keyword>Mitral Valve Repair</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Left Ventricular Dysfunction</keyword>
</DOC>